Feature Channels: Liver Disease

Filters close
Newswise:Video Embedded tumor-destroying-soundwaves-receive-fda-approval-for-liver-treatment-in-humans
VIDEO
Released: 13-Oct-2023 8:05 AM EDT
Tumor-destroying soundwaves receive FDA approval for liver treatment in humans
Michigan Medicine - University of Michigan

The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.

Newswise: New study unveils the novel factor FGF18 as a pivotal driver of liver fibrosis
Released: 11-Oct-2023 5:05 PM EDT
New study unveils the novel factor FGF18 as a pivotal driver of liver fibrosis
Toho University

Liver fibrosis is associated with various liver injuries, including viral infection, inflammation, excess alcohol consumption, and metabolic dysfunction.

Released: 2-Oct-2023 10:05 AM EDT
Multi-omics research on liver disease in Hispanics/Latinos funded through $4M NIH grant to UTHealth Houston
University of Texas Health Science Center at Houston

As one of just six sites in the country chosen for a new consortium of the National Institutes of Health (NIH), UTHealth Houston School of Public Health in Brownsville will use multi-omics in combination with environmental, epidemiologic, and clinical data, along with social determinants of health, to study non-alcoholic and non-viral liver disease in Hispanics/Latinos.

Released: 27-Sep-2023 1:05 PM EDT
Genetic variation with MASLD reveals subtypes and potential therapeutic avenues
Michigan Medicine - University of Michigan

A study reveals genetic subtypes, biomarkers, gene and pathway targets for the development of new treatments for this liver disease

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Newswise: Research identifies new potential hurdle for nano-based therapies
17-Sep-2023 8:00 PM EDT
Research identifies new potential hurdle for nano-based therapies
University of Texas MD Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body’s ability to respond to treatment.

Released: 11-Sep-2023 12:05 PM EDT
Alerta para los expertos: Expertos advierten sobre la enfermedad hepática silenciosa que crece entre hispanos y niños
Mayo Clinic

La cirrosis a menudo es consecuencia del consumo de alcohol crónico a largo plazo. Sin embargo, algunas personas que consumen poco o nada de alcohol pueden presentar cirrosis.

Released: 11-Sep-2023 11:05 AM EDT
Opinião de especialistas: O avanço silencioso de uma doença do fígado entre hispânicos e crianças é preocupante
Mayo Clinic

A cirroseé geralmente associada ao consumo prolongado e excessivo de álcool. No entanto, algumas pessoas que consomem pouco ou nenhum álcool podem acabar desenvolvendo a doença.

Released: 8-Sep-2023 11:05 AM EDT
Liver cancer and severe liver disease more common if a close relative has fatty liver disease
Karolinska Institute

Close relatives of people with metabolic-associated fatty liver disease have a higher risk of developing liver cancer and dying from liver-related diseases, according to a national study from Karolinska Institute in Sweden published in The Journal of Hepatology.

Newswise: Liver-Associated and Age-Related Studies Included in the September Issue of AJG
Released: 7-Sep-2023 10:00 AM EDT
Liver-Associated and Age-Related Studies Included in the September Issue of AJG
American College of Gastroenterology (ACG)

Research updates in gastroenterology and hepatology from the September issue of The American Journal of Gastroenterology, the flagship journal of the American College of Gastroenterology.

Newswise: Study: Race, Ethnicity May Play a Role in Cause of Liver Cancer
29-Aug-2023 6:05 PM EDT
Study: Race, Ethnicity May Play a Role in Cause of Liver Cancer
Sylvester Comprehensive Cancer Center

Race and ethnicity may play a role in liver cancer, which disproportionately affects people of low socioeconomic status, as well as immigrants, veterans and incarcerated populations.

Newswise: The Tiny Fish With Big Impact
Released: 30-Aug-2023 8:05 PM EDT
The Tiny Fish With Big Impact
Children's Hospital Los Angeles

The zebrafish is one of the most powerful biomedical research tools in use today. Children's Hospital Los Angeles is using them to better understand what causes pediatric cancer.

   
Released: 24-Aug-2023 11:05 AM EDT
Gene therapy study identifies potential new treatment for liver cancer
UC Davis Health

Gene therapy with microRNA-22 produced better survival outcomes than the current FDA-approved drug for liver cancer and without noticeable toxicity in new mouse study.

Newswise: Clinical Trial Studying Possible New Treatment Option for Patients with NAFLD
Released: 23-Aug-2023 11:05 AM EDT
Clinical Trial Studying Possible New Treatment Option for Patients with NAFLD
UC San Diego Health

$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.

Released: 22-Aug-2023 10:05 AM EDT
Paired liver exchange developed by Boston College economists results in first four-way liver exchange
Boston College

In a breakthrough in liver transplantation that may lead to the ability to connect more living donors and patients, a new matching system designed by a team led by Boston College economists enabled the world’s first four-way liver exchange and a cascade of additional matches.

Released: 21-Aug-2023 2:05 PM EDT
Research aims to uncover genetic and environmental risk factors of nonalcoholic fatty liver disease
Wayne State University Division of Research

A $3 million, five-year award from the National Institute of Environmental Health Sciences of the NIH aims to discover and validate the gene Х heavy metal (GXM) interactions in human livers and to understand their role in nonalcoholic fatty liver disease

Newswise: Cedars-Sinai Ilustra el Futuro de la Atención Médica con Inteligencia Artificial
Released: 15-Aug-2023 12:35 PM EDT
Cedars-Sinai Ilustra el Futuro de la Atención Médica con Inteligencia Artificial
Cedars-Sinai

La inteligencia artificial (IA) está capturando la imaginación del público a medida que el ritmo de la innovación se acelera considerablemente y las herramientas de IA fáciles de usar ofrecen nuevas posibilidades para transformar industrias enteras.

   
Released: 15-Aug-2023 8:50 AM EDT
FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma
Moffitt Cancer Center

The Food and Drug Administration announced yesterday the approval of HEPZATO Kit to treat ocular melanoma that has spread to the liver. HEPZATO uses a hepatic delivery system to inject the chemotherapy drug melphalan into the liver, a procedure referred to as percutaneous hepatic perfusion (PHP). Moffitt Cancer Center’s Jonathan S. Zager, M.D., was the lead international principal investigator on the multinational FOCUS phase 3 clinical trial to test the procedure, which is manufactured by Delcath Systems, Inc.

Newswise: Cedars-Sinai Charts Healthcare’s Future With Artificial Intelligence
Released: 14-Aug-2023 11:55 AM EDT
Cedars-Sinai Charts Healthcare’s Future With Artificial Intelligence
Cedars-Sinai

Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates sharply and easy-to-use AI tools offer new possibilities to transform whole industries.

   


close
1.95975